Matthew Hammond, Ph.D.


Matthew Hammond is a Principal on the Investment Team at RA Capital Management. Matthew works on both public and private investments and serves as a Director for Cerebral Therapeutics, DTx Pharma, Forge Biologics, Kira Pharmaceuticals, and Research Alliance Corp II. Matthew holds a BS in Environmental Health Science from the University of Georgia and both a PhD in Biomedical Science and an MBA with a concentration in Finance from the University of Connecticut. His graduate research investigated innate immune responses after intracerebral hemorrhage.